top of page

Nelson Advisors: NHS Health IT Market Forecast to Hit £8.3 Billion by 2030 as Productivity Pressures Mount

Writer: Nelson Advisors
Nelson Advisors
1 hour ago
9 min read
Nelson Advisors: NHS Health IT Market Forecast to Hit £8.3 Billion by 2030 as Productivity Pressures Mount
Nelson Advisors: NHS Health IT Market Forecast to Hit £8.3 Billion by 2030 as Productivity Pressures Mount

The NHS IT market is entering one of its most consequential growth phases in years. New analysis from Future Health Intelligence (FHI) forecasts that spending on NHS technology will climb from £6.1bn today to £8.3bn by 2030, adding more than £2bn in new market value over the next four years and cementing digital health as one of the fastest-growing corners of the UK public sector IT landscape. For an industry that has weathered its share of false starts and stop-go funding cycles, this is a striking signal: the direction of travel is not just upward, it's accelerating.


The forecast was unveiled during an FHI webinar on 11th September, drawing on the FHI Market Model, a proprietary framework that tracks current and projected health IT spend across five categories. It's a number worth sitting with. An annual growth rate of 6.1% between 2025 and 2030 would outpace general public sector IT spending growth in most comparable forecasts, and it arrives at a moment when the NHS is under sustained pressure to do more with less.


That combination, rising technology investment inside a service otherwise being asked to hold costs flat, is exactly the tension that makes this market interesting to suppliers, investors, and NHS leaders alike.

Why the Money Keeps Flowing


The politics around NHS funding are, as ever, unsettled. Tola Sargeant, associate director at FHI, addressed this directly in comments to Digital Health News, noting that there is real uncertainty over how government spending priorities might shift under Andy Burnham as prime minister. It's a fair note of caution. Changes in political leadership have, historically, come with changes in departmental priorities, spending review timetables, and appetite for large-scale technology programmes. Anyone who lived through the shifting fortunes of the National Programme for IT, or the various restructurings of NHS Digital and NHSX, knows that NHS technology strategy rarely survives a change of government untouched.


And yet Sargeant's core message was one of confidence rather than caution: "NHS investment in digital, data and tech is set to remain significant and growing over the next five years as the government strives to improve NHS productivity and the quality of services without increasing costs." That's the crux of it. Digital investment in the NHS has increasingly become decoupled from the question of whether a given government is "pro-tech" or not, and recoupled instead to a much harder, more structural problem: the NHS cannot meaningfully improve productivity through headcount growth alone, and the political room to simply spend more on frontline services without offsetting efficiency gains has narrowed considerably. Technology is one of the few levers left that can plausibly deliver more care without proportionally more money, more staff, or more beds.


Sargeant's second point is arguably even more significant for anyone selling into or investing in this market: "Against a backdrop of reorganisation and workforce changes, external support will be key to delivering this step-change, creating opportunities for IT suppliers."


NHS organisations undergoing structural change, trust mergers, integrated care board reconfigurations, workforce reductions in corporate and back-office functions, typically lose exactly the kind of in-house digital capability and organisational memory needed to run large technology programmes well. That capability gap doesn't close the funding tap; if anything, it widens the addressable market for external suppliers, consultancies, and managed service providers who can plug the gap. Reorganisation, in other words, tends to be good for supplier revenue even when it's disruptive for NHS IT teams themselves.


Where the Growth Is Concentrated


The FHI Market Model breaks local NHS IT spending into five categories: software, IT services, networking and communications, hardware, and other spending (which includes ICT staff costs). Of these, software is comfortably the largest, accounting for 35% of total local NHS IT spending in 2025/26. FHI's analysis predicts that share will grow further still, to 37% by 2030/3, a notable finding given how mature the electronic patient record (EPR) market already is in England. Most acute trusts have now either completed or are well into major EPR replacement or upgrade programmes, which might reasonably be expected to plateau software spend as a proportion of the whole. That FHI instead sees software's share continuing to rise suggests the next wave of growth isn't really about EPRs at all, it's about what gets built and bought around and on top of them.


That next wave has a fairly clear shape. FHI singles out AI led software, with ambient voice technology (AVT) called out specifically, alongside cyber security software, remote monitoring systems, and patient engagement tools as the areas earmarked for the strongest growth. Each of these tells its own story about where NHS priorities are heading.


Ambient voice technology, which automatically listens to and documents clinical consultations, has moved from pilot curiosity to genuine procurement category in a remarkably short space of time. It sits squarely inside the productivity narrative Sargeant described: it doesn't require new clinical headcount, it directly attacks one of the most persistent drains on clinician time (documentation), and it can be deployed incrementally across existing EPR infrastructure rather than requiring a rip and replace programme. Expect continued consolidation and expansion in this category as trusts move from pilots to at scale rollout.

Cyber security spend, meanwhile, reflects a threat landscape that has only intensified. The NHS has experienced a string of high-profile ransomware and supply-chain incidents in recent years, several of which caused significant clinical disruption, and cyber resilience has become a board-level and regulatory priority rather than a purely technical one. Growth here is less discretionary than in other categories, it's substantially compliance and risk-driven, which tends to make it a more defensible long-term revenue line for suppliers than categories more exposed to policy or funding swings.


Remote monitoring and patient engagement tools both point toward a shift in where care is delivered and who is expected to manage it. Virtual wards, remote monitoring of long-term conditions, and digital front door tools for patient access and self management all reduce reliance on physical estate and face to face capacity, both of which are far more expensive and far slower to expand than software licences. As the NHS continues to grapple with elective backlogs, ageing infrastructure, and constrained capital budgets, technology that shifts care out of buildings and into homes carries an obvious appeal.


How FHI Builds the Forecast


It's worth understanding the methodology behind these numbers, because it shapes how much weight to put on them. The FHI Market Model isn't a survey-based estimate or a simple extrapolation of historical trend lines. It draws on analysis of actual procurement awards, contracts that have been signed and published, combined with supplier financial data, to build a picture of current local NHS IT spending across the five categories described above. That bottom-up, evidence based starting point is then projected forward using published government spending plans and stated policy commitments, rather than FHI's own assumptions about what should happen.


This matters because it means the £8.3bn 2030 figure isn't a hopeful industry projection; it's derived from money the government has already committed to spending, layered on top of observed current spending patterns and known procurement activity. That doesn't make it immune to disruption, spending review outcomes, changes in NHS financial planning, or a change in government priorities could all move the number, but it does mean the forecast has a firmer evidential footing than the kind of top-down market-sizing exercises that are common (and commonly wrong) in health tech.


The Baseline: What We Already Know About NHS Trust IT Spend


The 2030 forecast builds on FHI's earlier analysis, published in February 2026, which found that total IT spend by NHS trusts across the UK reached £4.1bn in 2024/25, a 9% increase on the previous year. That single data point is worth pausing on: a 9% year-on-year increase is, by any standard, rapid growth for a public sector spending category, and it suggests the acceleration FHI is now forecasting through to 2030 isn't a break from recent trend but a continuation of one already underway.

The February analysis also sheds useful light on where that spending is actually happening. England accounted for 87% of total UK local NHS trust IT spending in 2024/25, an outsized share relative to England's roughly 84% share of the UK population, reflecting both the scale of the English NHS and the intensity of its digital transformation programmes relative to the devolved health services in Scotland, Wales, and Northern Ireland. Within England, the split by trust type is heavily skewed toward acute care: acute trusts accounted for 80% of local NHS IT spending, with mental health trusts responsible for 18% and community trusts just 2%.


That imbalance is a familiar and long standing feature of NHS digital investment, and one that periodically attracts criticism from mental health and community care advocates who argue their sectors remain digitally under-resourced relative to acute care despite carrying significant and growing caseloads. Given the strong growth forecast for remote monitoring and patient engagement tools, categories that arguably have as much or more relevance to community and long-term condition management as to acute episodic care, it will be worth watching in future FHI updates whether that 80/18/2 split begins to shift, or whether acute trusts continue to capture a disproportionate share of new digital investment even in categories theoretically suited to community deployment.


Who's Spending the Most


FHI's trust-level data also names names. Guy's and St Thomas' NHS Foundation Trust recorded the highest IT spend of any acute trust in 2024/25, at £109m. Manchester University NHS Foundation Trust followed at £90m, with University Hospitals Birmingham NHS Foundation Trust third at £68m.


There's a pattern worth noting here beyond the raw rankings: all three are large, multi-site acute trusts serving major urban populations, each of which has been through significant EPR and digital infrastructure investment in recent years. Guy's and St Thomas', for instance, has been one of the more prominent adopters of advanced digital and AI-enabled clinical tools in the NHS, and its position at the top of the spending table is consistent with a broader pattern where the trusts with the most mature digital strategies also tend to be the biggest spenders, digital maturity and digital investment reinforce one another rather than digital investment simply "catching up" less mature organisations to the leaders.


For suppliers and investors assessing where to focus commercial effort, this concentration of spend among a relatively small number of large, digitally sophisticated trusts is a significant structural feature of the market: it rewards vendors who can build credibility and reference deployments with tier-one trusts, since those relationships tend to be both the largest contracts and the most influential in shaping wider market perception.


What This Means for the Market


Step back from the individual data points and a coherent picture emerges. This is a market growing faster than the wider public sector, growing for structural rather than cyclical reasons, and growing in a reasonably predictable, policy anchored way rather than through one off funding windfalls. For companies operating in or adjacent to NHS IT, software vendors, systems integrators, managed service providers, and the investors who back them, that combination of scale, growth rate, and predictability is unusual and valuable.


It also has clear implications for how the market is likely to consolidate over the coming years. A sector forecast to add over £2bn in new spend by 2030, concentrated heavily in software and services rather than hardware, and skewed toward categories like AI-enabled clinical tools, cyber security, and remote care, is precisely the kind of environment that tends to attract private equity and strategic acquirers looking to build scale, broaden product portfolios, or buy their way into categories with strong structural tailwinds.


Smaller specialist vendors in ambient voice technology, remote monitoring, and patient engagement in particular are likely to see increased acquisition interest as larger health tech platforms and international entrants look to establish or consolidate a UK NHS footprint ahead of the growth FHI is now forecasting. Trusts' own reorganisation-driven reliance on external suppliers, as Sargeant noted, only adds to the appeal of building scaled service capability that can be deployed flexibly across a changing NHS structure.

There are, of course, real risks to the forecast holding. A change in government spending priorities under a new prime minister, a disappointing spending review settlement, or a renewed bout of NHS financial distress leading to short-term capital and IT budget freezes have all disrupted digital investment plans before, sometimes sharply. FHI's own framing acknowledges this uncertainty even as it maintains confidence in the underlying trajectory. But the structural case for continued NHS IT growth — an ageing population, a workforce that cannot expand indefinitely, and a political consensus (however contested at the margins) that productivity gains must come from somewhere — remains intact regardless of who occupies Downing Street.


For now, the direction is clear. From £6.1bn to £8.3bn in five years, with software, AI-enabled clinical tools, cyber security, and remote care leading the charge: the NHS IT market looks set to remain one of the more compelling growth stories in UK public sector technology for the rest of this decade.


Nelson Advisors > European HealthTech, MedTech, Digital Health Investment Banking

 

Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, MedTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies.www.nelsonadvisors.co.uk


Nelson Advisors regularly publish Thought Leadership articles covering market insights, industry trends, deal commentary, market analysis & predictions @ https://www.healthcare.digital 


Nelson Advisors publish Europe's Leading Healthcare Technology Investment Banking Newsletter every week, join 5000+ HealthTech and MedTech subscribers today! https://lnkd.in/e5hTp_xb 


Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards, corporates, venture capital and private investors to maximise shareholder value and investment returns.www.nelsonadvisors.co.uk



Nelson Advisors LLP

 

Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT




Meet Nelson Advisors @ 2026 Events

 

Digital Health Rewired > March 2026 > Birmingham, UK 

 

NHS ConfedExpo  > June 2026 > Manchester, UK 

 

HLTH Europe > June 2026, Amsterdam, Netherlands

 

HIMSS AI in Healthcare > July 2026, New York, USA

 

Bits & Pretzels > September 2026, Munich, Germany  

 

World Health Summit 2026 > October 2026, Berlin, Germany

 

HealthInvestor Healthcare Summit > October 2026, London, UK 


HLTH USA 2026 > October 2026, USA

 

Barclays Health Elevate > October 2026, London, UK 

 

Web Summit 2026 > November 2026, Lisbon, Portugal  

 

MEDICA 2026 > November 2026, Düsseldorf, Germany

 

Venture Capital World Summit > December 2026 Toronto, Canada


Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, MedTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies.www.nelsonadvisors.co.uk
Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, MedTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies.www.nelsonadvisors.co.uk

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page